Dexco (B3: DXCO3) stock: the official figures
Dexco (Dexco S.A.) is listed on B3, the São Paulo stock exchange, under the ticker DXCO3. In fiscal 2025 it reported revenue of BRL 8,249m and a net profit of BRL 1.2m, according to the annual accounts it filed with the regulator.
Identifiers for Dexco: CNPJ 97.837.181/0001-47.
Fiscal 2025 figures
| Item | 2025 | 2024 | Change |
|---|---|---|---|
| Revenue | BRL 8,249m | BRL 8,235m | +0.2% |
| Operating profit | BRL 740.3m | BRL 936.5m | −21.0% |
| Net profit | BRL 1.2m | BRL 172.4m | −99.3% |
| Operating margin | 9.0% | 11.4% | −2.4 pts |
| Net margin | 0.0% | 2.1% | −2.1 pts |
| Total assets | BRL 19,001m | BRL 18,144m | +4.7% |
| Equity | BRL 6,847m | BRL 6,977m | −1.9% |
| Cash | BRL 2,178m | BRL 1,231m | +76.9% |
| Operating cash flow | BRL 850.6m | BRL 1,284m | −33.7% |
Margins are calculated from the filed figures: operating profit and net profit over revenue.
10 fiscal years
| Fiscal year | Revenue | Operating profit | Net profit | Document |
|---|---|---|---|---|
| 2025 | BRL 8,249m | BRL 740.3m | BRL 1.2m | Annual report |
| 2024 | BRL 8,235m | BRL 936.5m | BRL 172.4m | Annual report |
| 2023 | BRL 7,383m | BRL 1,270m | BRL 789.6m | Annual report |
| 2022 | BRL 8,487m | BRL 1,449m | BRL 755.9m | Annual report |
| 2021 | BRL 8,170m | BRL 1,891m | BRL 1,725m | Annual report |
| 2020 | BRL 5,880m | BRL 671.9m | BRL 453.8m | Annual report |
| 2019 | BRL 5,012m | BRL 639.4m | BRL 405.6m | Annual report |
| 2018 | BRL 4,949m | BRL 732.7m | BRL 431.6m | Annual report |
| 2017 | BRL 3,991m | BRL 421.3m | BRL 184.9m | Annual report |
| 2016 | BRL 3,910m | BRL 317.1m | BRL 23.6m | Annual report |
The full income statement, balance sheet and cash flow statement are in the annual accounts of Dexco. Year by year: revenue, net income and dividends paid.
Dividends
In fiscal 2025, Dexco paid BRL 45.5m in dividends, 3,852.4% of its net profit, according to its cash flow statement.
| Fiscal year | Dividends paid | Share of net profit |
|---|---|---|
| 2025 | BRL 45.5m | 3,852.4% |
| 2024 | BRL 233.9m | 135.6% |
| 2023 | BRL 248.8m | 31.5% |
| 2022 | BRL 0.1m | 0.0% |
| 2021 | BRL 1,394m | 80.8% |
| 2020 | BRL 257.3m | 56.7% |
| 2019 | BRL 545.8m | 134.6% |
| 2018 | BRL 60.8m | 14.1% |
| 2017 | BRL 6.1m | 3.3% |
| 2016 | BRL 105.5m | 446.2% |
Cash paid out as dividends during the fiscal year, including dividends to minority shareholders of subsidiaries when the company does not report them separately. It is not the dividend per share.
Frequently asked questions about Dexco
- How much did Dexco earn in fiscal 2025?
- Dexco reported a net profit of BRL 1.2m for fiscal 2025, on revenue of BRL 8,249m. The year before it reported a net profit of BRL 172.4m.
- Does Dexco pay a dividend?
- In fiscal 2025, Dexco paid BRL 45.5m in dividends, 3,852.4% of its net profit, according to its cash flow statement.
- Where is Dexco listed?
- Dexco is listed on B3, the São Paulo stock exchange, under the ticker DXCO3.
- Where do the figures for Dexco come from?
- From the annual financial statements (DFP) that Dexco files with the CVM, the Brazilian securities regulator. Each fiscal year links to its filing.
Where each figure comes from
The annual accounts come from the annual financial statements (DFP) that Dexco files with the CVM, the Brazilian securities regulator. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.